0.673
price up icon5.49%   0.035
after-market Dopo l'orario di chiusura: .64 -0.033 -4.90%
loading
Precedente Chiudi:
$0.638
Aprire:
$0.62
Volume 24 ore:
82,036
Relative Volume:
2.16
Capitalizzazione di mercato:
$29.27M
Reddito:
-
Utile/perdita netta:
$-13.25M
Rapporto P/E:
-1.9049
EPS:
-0.3533
Flusso di cassa netto:
$-8.02M
1 W Prestazione:
+4.99%
1M Prestazione:
-6.79%
6M Prestazione:
-44.84%
1 anno Prestazione:
-35.90%
Intervallo 1D:
Value
$0.62
$0.74
Intervallo di 1 settimana:
Value
$0.585
$0.74
Portata 52W:
Value
$0.585
$3.15

Estrella Immunopharma Inc Stock (ESLA) Company Profile

Name
Nome
Estrella Immunopharma Inc
Name
Telefono
(510) 318-9098
Name
Indirizzo
5858 HORTON STREET, SUITE 370, EMERYVILLE
Name
Dipendente
0
Name
Cinguettio
Name
Prossima data di guadagno
2026-05-13
Name
Ultimi documenti SEC
Name
ESLA's Discussions on Twitter

Compare ESLA vs VRTX, REGN, ARGX, MRNA, RVMD

Azioni Prezzo Cap. di mercato Reddito Reddito netto Flusso di cassa EPS
ESLA icon
ESLA
Estrella Immunopharma Inc
0.673 27.75M 0 -13.25M -8.02M -0.3533
VRTX icon
VRTX
Vertex Pharmaceuticals Inc
514.56 132.08B 12.34B 4.34B 3.71B 16.87
REGN icon
REGN
Regeneron Pharmaceuticals Inc
793.26 83.15B 14.92B 4.42B 3.79B 41.04
ARGX icon
ARGX
Argen X Se Adr
984.04 62.71B 4.16B 1.29B 734.26M 19.58
MRNA icon
MRNA
Moderna Inc
136.62 54.14B 2.23B -3.19B -1.60B -8.1462
RVMD icon
RVMD
Revolution Medicines Inc
203.35 44.51B 742.00K -1.37B -1.07B -7.0731

Estrella Immunopharma Inc Borsa (ESLA) Ultime notizie

pulisher
Sep 08, 2026

Estrella Immunopharma Faces Nasdaq Listing Compliance Challenge - TipRanks

Sep 08, 2026
pulisher
Sep 08, 2026

Estrella Immunopharma Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView

Sep 08, 2026
pulisher
Aug 21, 2026

Estrella Immunopharma Receives Nasdaq Minimum Bid Price Notice - TipRanks

Aug 21, 2026
pulisher
Aug 20, 2026

ARMISTICE CAPITAL, LLC Reduces Stake in Estrella Immunopharma Inc (ESLA) by Nearly Half - GuruFocus

Aug 20, 2026
pulisher
Aug 18, 2026

Estrella Immunopharma Inc. (NASDAQ: ESLA) Share Price, ESLA Stock News, ESLA Share Price & Updates - Kalkine

Aug 18, 2026
pulisher
Aug 16, 2026

Estrella Immunopharma (ESLA) Holds Ground at $0.72 as Immunotherapy Pipeline Takes Center StageLong Short Pair - vinanet.vn

Aug 16, 2026
pulisher
Aug 16, 2026

Price to earnings forward of Estrella Immunopharma, Inc. – NASDAQ:ESLA - TradingView

Aug 16, 2026
pulisher
Aug 15, 2026

Estrella Immunopharma (ESLA) Holds at $0.72 as Support Firms in Quiet Micro-Cap SessionIchimoku TK Cross - vinanet.vn

Aug 15, 2026
pulisher
Aug 15, 2026

ESLAW Warrants Hold Flat at $0.07 as Support and Resistance AlignInstitutional Buy Signals - vinanet.vn

Aug 15, 2026
pulisher
Aug 14, 2026

ESLAW Warrant Holds at $0.07 as Estrella Immunopharma Trades FlatSystematic Flow - vinanet.vn

Aug 14, 2026
pulisher
Aug 14, 2026

Estrella Immunopharma (ESLA): Armistice Capital discloses 4.99% ownership stake - Stock Titan

Aug 14, 2026
pulisher
Aug 13, 2026

Estrella Immunopharma, Inc. 2Q 2026: Net loss $(2.31M), EPS $(0.05) — 10-Q Summary - TradingView

Aug 13, 2026
pulisher
Aug 13, 2026

Tranche Update on Estrella Immunopharma, Inc.'s Equity Buyback Plan announced on January 30, 2024. - marketscreener.com

Aug 13, 2026
pulisher
Aug 11, 2026

Estrella Immunopharma Activates University Hospitals Cleveland Medical Center as Fourth Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - BioSpace

Aug 11, 2026
pulisher
Aug 11, 2026

Estrella adds fourth site to EB103 lymphoma trial - Investing.com

Aug 11, 2026
pulisher
Aug 08, 2026

Estrella Immunopharma Inc (ESLA) Stock News Today - TradingKey

Aug 08, 2026
pulisher
Aug 07, 2026

Estrella Immunopharma (ESLA) Stock Price, News & Analysis - MarketBeat

Aug 07, 2026
pulisher
Aug 06, 2026

Estrella Immunopharma Inc (ESLA) Earnings Forecast: Future EPS & Revenue Growth Estimates - TradingKey

Aug 06, 2026
pulisher
Aug 05, 2026

12 Health Care Stocks Moving In Wednesday's Pre-Market Session - Benzinga

Aug 05, 2026
pulisher
Aug 05, 2026

Estrella Immunopharma (ESLA) Rallies 6.11% as CAR T-Cell Focus Draws Investor AttentionEarnings Sentiment - vinanet.vn

Aug 05, 2026
pulisher
Aug 04, 2026

Price to book forward of Estrella Immunopharma, Inc. – NASDAQ:ESLAW - tradingview.com

Aug 04, 2026
pulisher
Aug 03, 2026

Estrella adds third site to EB103 lymphoma trial - Investing.com

Aug 03, 2026
pulisher
Aug 03, 2026

Estrella adds third site to EB103 lymphoma trial By Investing.com - Investing.com South Africa

Aug 03, 2026
pulisher
Aug 02, 2026

Estrella Immunopharma (ESLA) Holds at $0.71 as Downside Pressures Remain ContainedTRIN Signal - dars.gov.et

Aug 02, 2026
pulisher
Aug 02, 2026

Price to sales forward of Estrella Immunopharma, Inc. – BOATS:ESLAW - TradingView

Aug 02, 2026
pulisher
Aug 02, 2026

Price to book forward of Estrella Immunopharma, Inc. – NASDAQ:ESLA - TradingView

Aug 02, 2026
pulisher
Jul 29, 2026

Estrella activates second site for EB103 lymphoma trial By Investing.com - Investing.com Canada

Jul 29, 2026
pulisher
Jul 29, 2026

Estrella Immunopharma Activates Baylor Scott & White Research Institute as Second Clinical Site for Phase I/II STARLIGHT-1 Trial in B-cell Non-Hodgkin’s Lymphoma - Yahoo Finance

Jul 29, 2026
pulisher
Jul 27, 2026

Estrella Immunopharma Inc (ESLA) Technical Analysis: Support, Resistance, Indicators & Moving Averages - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Estrella Immunopharma Inc (ESLA) Revenue Breakdown: Business Segments, Regional Revenue & Profit Contribution - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Estrella Immunopharma Inc (ESLA) Dividends & Stock Splits: Historical Payouts and Event Timeline - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Estrella Immunopharma Inc (ESLA) Financial Health: Profitability & Balance Sheet Analysis - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Estrella Immunopharma Inc (ESLA) Balance Sheet - TradingKey

Jul 27, 2026
pulisher
Jul 27, 2026

Estrella Immunopharma Inc (ESLA) Cash Flow - TradingKey

Jul 27, 2026
pulisher
Jul 26, 2026

Estrella Immunopharma Inc (ESLA) Shareholder Structure: Major Shareholders & Institutional Holdings - TradingKey

Jul 26, 2026
pulisher
Jul 26, 2026

ESLA|Estrella Immunopharma Inc|Price:0.750|Chg%:-0.030 - TradingKey

Jul 26, 2026
pulisher
Jul 25, 2026

TradingKey - TradingKey

Jul 25, 2026
pulisher
Jul 25, 2026

Estrella Immunopharma Inc (ESLA) Valuation: PE, PB & Fair Value Analysis - TradingKey

Jul 25, 2026
pulisher
Jul 24, 2026

Estrella Immunopharma Inc (ESLA) Risk Assessment: Volatility, Financial Risk & Investment Risk - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

ESLA|Estrella Immunopharma Inc|Price:0.780| - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Estrella Immunopharma Inc (ESLA) Institutional Confidence - TradingKey

Jul 24, 2026
pulisher
Jul 24, 2026

Estrella doses first patient in EB103 trial expansion phase - Investing.com

Jul 24, 2026
pulisher
Jul 24, 2026

Estrella doses first patient in EB103 trial expansion phase By Investing.com - Investing.com Canada

Jul 24, 2026
pulisher
Jul 24, 2026

Estrella Immunopharma Announces First Patient Dosed in Dose-Expansion Phase of STARLIGHT-1 Trial and Reports Durable Response Rate in Advanced B-Cell Non-Hodgkin’s Lymphoma - Yahoo Finance

Jul 24, 2026
pulisher
Jul 23, 2026

Price to sales forward of Estrella Immunopharma, Inc. – NASDAQ:ESLAW - TradingView

Jul 23, 2026
pulisher
Jul 22, 2026

Enterprise value to EBITDA forward of Estrella Immunopharma, Inc. – NASDAQ:ESLAW - TradingView

Jul 22, 2026
pulisher
Jul 19, 2026

Enterprise value to EBIT forward of Estrella Immunopharma, Inc. – NASDAQ:ESLAW - TradingView

Jul 19, 2026
pulisher
Jul 19, 2026

Estrella Immunopharma, Inc. (ESLA) stock price, news, quote and history - Yahoo Finance UK

Jul 19, 2026
pulisher
Jul 17, 2026

Estrella Immunopharma Inc. (ESLA) Q2 2026 Earnings: Wider-than-Expected Loss Despite Double-Digit Stock Rally - vinanet.vn

Jul 17, 2026
pulisher
Jul 16, 2026

Enterprise value to revenue forward of Estrella Immunopharma, Inc. – NASDAQ:ESLAW - TradingView

Jul 16, 2026
pulisher
Jul 16, 2026

Estrella Immunopharma Warrants (ESLAW) Slide 7.5% as Support and Resistance Converge at $0.08Ichimoku Kumo Twist - vinanet.vn

Jul 16, 2026

Estrella Immunopharma Inc Azioni (ESLA) Dati Finanziari

Reddito

loading

Reddito netto

loading

Flusso di cassa

loading

EPS

loading
$58.75
price down icon 3.04%
$127.28
price down icon 1.18%
$40.94
price down icon 2.08%
$247.51
price down icon 4.07%
ONC ONC
$341.80
price down icon 2.62%
$203.35
price down icon 2.08%
Capitalizzazione:     |  Volume (24 ore):